Product Overview

Silofirst 4 contains Silodosin, a highly selective alpha-1A adrenergic receptor blocker developed for the effective management of Benign Prostatic Hyperplasia (BPH). It is widely prescribed to relieve lower urinary tract symptoms caused by an enlarged prostate, including difficulty in urination, weak urinary stream, urinary hesitancy, increased urinary frequency, nocturia, and the sensation of incomplete bladder emptying.

Silodosin works by selectively relaxing the smooth muscles of the prostate, bladder neck, and urethra, allowing urine to flow more freely without affecting the size of the prostate. Due to its high selectivity for alpha-1A receptors, Silofirst 4 provides effective symptom relief while minimizing the impact on blood pressure compared to non-selective alpha blockers.

Silofirst 4 is suitable for long-term management of BPH and helps improve urinary function, patient comfort, and overall quality of life. Manufactured under stringent pharmaceutical quality standards, it offers consistent efficacy, safety, and reliability for the effective treatment of urinary symptoms associated with BPH.

How It Works

Silodosin selectively blocks alpha-1A adrenergic receptors located in the prostate, bladder neck, and prostatic urethra. This action relaxes smooth muscle tissue, reduces bladder outlet resistance, and improves urinary flow. As a result, patients experience relief from urinary urgency, hesitancy, weak stream, and incomplete bladder emptying while improving overall bladder function.

Therapeutic Applications

Silofirst 4 may be prescribed for the management of:

• Benign Prostatic Hyperplasia (BPH)
• Lower Urinary Tract Symptoms (LUTS)
• Difficulty in Urination
• Weak Urinary Stream
• Urinary Hesitancy
• Frequent Urination
• Nocturia
• Incomplete Bladder Emptying

Key Benefits

• Highly selective alpha-1A receptor blocker.
• Improves urinary flow and bladder emptying.
• Helps reduce urinary urgency and frequency.
• Relieves lower urinary tract symptoms associated with BPH.
• Suitable for long-term BPH management.
• Manufactured under stringent pharmaceutical quality standards.

Quality Commitment

Vinix Biopharma is committed to delivering high-quality urology products manufactured in accordance with stringent pharmaceutical quality standards. Silofirst 4 undergoes comprehensive quality assurance procedures and rigorous testing to ensure safety, efficacy, consistency, and reliability. Every batch is carefully evaluated to maintain product integrity and support optimal patient care.

Storage Information

Store in a cool, dry place below 30°C. Protect from moisture and direct sunlight. Keep out of reach of children.

Disclaimer

Silofirst 4 should be used only under the supervision of a qualified healthcare professional. Dosage and duration of treatment should be determined by the treating physician based on the patient’s clinical condition, medical history, and therapeutic requirements.